FZR1 Antibody - #DF13027
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# DF13027, RRID:AB_2845988.
折りたたみ／展開
CDC20 like 1b; CDC20 like protein 1; CDC20-like protein 1; CDC20C; CDH1; Cdh1/Hct1 homolog; Fizzy related protein 1; Fizzy related protein; Fizzy related protein homolog; Fizzy-related protein homolog; Fizzy/cell division cycle 20 related 1; FYR; FZR 1; FZR 2; Fzr; FZR_HUMAN; Fzr1; Fzr1 protein; FZR2; HCDH 1; HCDH; hCDH1; KIAA1242;
免疫原
Isoform 2 is expressed at high levels in heart, liver, spleen and some cancer cell lines whereas isoform 3 is expressed only at low levels in these tissues.
- Q9UM11 FZR1_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MDQDYERRLLRQIVIQNENTMPRVTEMRRTLTPASSPVSSPSKHGDRFIPSRAGANWSVNFHRINENEKSPSQNRKAKDATSDNGKDGLAYSALLKNELLGAGIEKVQDPQTEDRRLQPSTPEKKGLFTYSLSTKRSSPDDGNDVSPYSLSPVSNKSQKLLRSPRKPTRKISKIPFKVLDAPELQDDFYLNLVDWSSLNVLSVGLGTCVYLWSACTSQVTRLCDLSVEGDSVTSVGWSERGNLVAVGTHKGFVQIWDAAAGKKLSMLEGHTARVGALAWNAEQLSSGSRDRMILQRDIRTPPLQSERRLQGHRQEVCGLKWSTDHQLLASGGNDNKLLVWNHSSLSPVQQYTEHLAAVKAIAWSPHQHGLLASGGGTADRCIRFWNTLTGQPLQCIDTGSQVCNLAWSKHANELVSTHGYSQNQILVWKYPSLTQVAKLTGHSYRVLYLAMSPDGEAIVTGAGDETLRFWNVFSKTRSTKVKWESVSVLNLFTRIR
種類予測
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - Q9UM11 基板として
| Site | PTM Type | Enzyme | Source |
|---|---|---|---|
| Phosphorylation | Uniprot | ||
| Y5 | Phosphorylation | Uniprot | |
| T30 | Phosphorylation | Uniprot | |
| T32 | Phosphorylation | Uniprot | |
| S35 | Phosphorylation | Uniprot | |
| S36 | Phosphorylation | Uniprot | |
| S39 | O-Glycosylation | Uniprot | |
| S39 | Phosphorylation | Uniprot | |
| S40 | O-Glycosylation | Uniprot | |
| S40 | Phosphorylation | P24941 (CDK2) , Q00535 (CDK5) | Uniprot |
| S42 | O-Glycosylation | Uniprot | |
| S42 | Phosphorylation | Uniprot | |
| K69 | Acetylation | Uniprot | |
| S70 | Phosphorylation | Uniprot | |
| S72 | Phosphorylation | Uniprot | |
| K86 | Ubiquitination | Uniprot | |
| Y91 | Phosphorylation | Uniprot | |
| S92 | Phosphorylation | Uniprot | |
| K96 | Ubiquitination | Uniprot | |
| K106 | Ubiquitination | Uniprot | |
| S120 | Phosphorylation | Uniprot | |
| T121 | Phosphorylation | P24941 (CDK2) , Q00535 (CDK5) | Uniprot |
| K125 | Sumoylation | Uniprot | |
| S131 | Phosphorylation | Uniprot | |
| S133 | Phosphorylation | Uniprot | |
| K135 | Ubiquitination | Uniprot | |
| S137 | Phosphorylation | Uniprot | |
| S138 | Phosphorylation | Uniprot | |
| S146 | Phosphorylation | Uniprot | |
| S151 | Phosphorylation | P24941 (CDK2) | Uniprot |
| S154 | Phosphorylation | Uniprot | |
| K156 | Ubiquitination | Uniprot | |
| K159 | Acetylation | Uniprot | |
| S163 | Phosphorylation | Q00535 (CDK5) , P24941 (CDK2) | Uniprot |
| K173 | Ubiquitination | Uniprot | |
| K262 | Ubiquitination | Uniprot | |
| K263 | Ubiquitination | Uniprot | |
| T300 | Phosphorylation | Uniprot | |
| K320 | Ubiquitination | Uniprot | |
| K336 | Ubiquitination | Uniprot | |
| S343 | Phosphorylation | Uniprot | |
| S346 | Phosphorylation | Uniprot | |
| K429 | Ubiquitination | Uniprot | |
| K475 | Ubiquitination | Uniprot |
研究背景
Substrate-specific adapter for the anaphase promoting complex/cyclosome (APC/C) E3 ubiquitin-protein ligase complex. Associates with the APC/C in late mitosis, in replacement of CDC20, and activates the APC/C during anaphase and telophase. The APC/C remains active in degrading substrates to ensure that positive regulators of the cell cycle do not accumulate prematurely. At the G1/S transition FZR1 is phosphorylated, leading to its dissociation from the APC/C. Following DNA damage, it is required for the G2 DNA damage checkpoint: its dephosphorylation and reassociation with the APC/C leads to the ubiquitination of PLK1, preventing entry into mitosis. Acts as an adapter for APC/C to target the DNA-end resection factor RBBP8/CtIP for ubiquitination and subsequent proteasomal degradation. Through the regulation of RBBP8/CtIP protein turnover, may play a role in DNA damage response, favoring DNA double-strand repair through error-prone non-homologous end joining (NHEJ) over error-free, RBBP8-mediated homologous recombination (HR).
Acetylated. Deacetylated by SIRT2 at Lys-69 and Lys-159; deacetylation enhances the interaction of FZR1 with CDC27, leading to activation of anaphase promoting complex/cyclosome (APC/C).
Phosphorylated during mitosis, probably by maturation promoting factor (MPF), leading to its dissociation of the APC/C. Following DNA damage, it is dephosphorylated by CDC14B in G2 phase, leading to its reassociation with the APC/C, and allowing an efficient G2 DNA damage checkpoint. Phosphorylated by MAK.
Nucleus.
Cytoplasm.
Isoform 2 is expressed at high levels in heart, liver, spleen and some cancer cell lines whereas isoform 3 is expressed only at low levels in these tissues.
The unphosphorylated form interacts with APC/C during mitosis. Interacts with NINL. Interacts (in complex with the anaphase promoting complex APC) with MAD2L2; inhibits FZR1-mediated APC/C activation. Interacts with SIRT2 and USP37. Interacts (via WD repeats) with MAK. Interacts with RBBP8/CtIP; this interaction leads to RBBP8 proteasomal degradation. Interacts with HECW2.
Belongs to the WD repeat CDC20/Fizzy family.
研究領域
· Cellular Processes > Cell growth and death > Cell cycle. (View pathway)
· Genetic Information Processing > Folding, sorting and degradation > Ubiquitin mediated proteolysis. (View pathway)
· Organismal Systems > Endocrine system > Progesterone-mediated oocyte maturation.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.